Abingworth LLP Reneo Pharmaceuticals, Inc. Transaction History

Abingworth LLP

  • $301 Million
  • Q4 2022

A detailed history of Abingworth LLP transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Abingworth LLP holds 2,073,957 shares of RPHM stock, worth $3.48 Million. This represents 1.6% of its overall portfolio holdings.

Number of Shares
2,073,957
Previous 2,073,957 -0.0%
Holding current value
$3.48 Million
Previous $6.95 Million 30.45%
% of portfolio
1.6%
Previous 2.38%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
BUY
$6.28 - $11.07 $701,702 - $1.24 Million
111,736 Added 5.69%
2,073,957 $15.3 Million
Q2 2021

Aug 16, 2021
BUY
$7.78 - $15.0 $15.3 Million - $29.4 Million
1,962,221 New
1,962,221 $18.2 Million

Others Institutions Holding RPHM

# of Institutions
13
Shares Held
12M
Call Options Held
0
Put Options Held
0
View Full List

About Reneo Pharmaceuticals, Inc.

RPHM Quotes by TradingView
  • Ticker RPHM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,479,600
  • Market Cap $41.1M
  • Description
  • Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...
More about RPHM
Track This Portfolio

Track Abingworth LLP Portfolio

Follow Abingworth LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abingworth LLP, based on Form 13F filings with the SEC.

News

Stay updated on Abingworth LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email